Hiroka Tanimizu

Ten-year institutional trends in syphilis: The first-contact role of otolaryngology and diagnostic pitfalls

Hiroaki Iijima, Akihiro Sakai, Mayu Yamauchi, Shota Sato et autres

Background and objective Syphilis, often referred to as “The Great Imitator,” can resemble malignant tumors in the head and neck region. Otolaryngologists (ENT) specialists frequently serve as the first point of evaluation for oropharyngeal lesions; however, quantitative data on ENT diagnostic patterns, …

jp (code pays fourni par la source)

Paclitaxel, carboplatin, and cetuximab induction chemotherapy for locally advanced head and neck squamous cell carcinoma: A retrospective evaluation of treatment outcomes and safety

Hiroaki Iijima, Akihiro Sakai, Mayu YAMAUCHI, Kazufumi OBATA et autres

Background/Purpose Definitive chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (HNSCC) has limitations in advanced disease. Paclitaxel, carboplatin, and cetuximab (PCE) offers a potentially safer induction chemotherapy alternative. This study evaluated the feasibility and outcomes of PCE induction followed …

jp (code pays fourni par la source)

Possible involvement of RhoA post-translational modification in cell morphogenesis.

Tomoyuki Araki, Satoshi Yoshida, Hiroka Tanimizu, Takayuki Murakoshi

us (code pays fourni par la source)